UniProt Q8GPI4
Bacteriocin aureocin A53 (Q8GPI4)
Bacteriocin aureocin A53 (UniProt Q8GPI4): 5 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound, 1 pocket. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q8GPI4
- Protein
- Bacteriocin aureocin A53
- Experimental structures
- 5
- Predicted models
- 1
- Ligands
- 1
- Pockets
- 1 · 0 records with a druggable one
Structures
6 records of Q8GPI4 in the MolNFT archive: 5 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2N8O | NMR Solution Structure of Aureocin A53 | solution nmr | A | — | — |
| 2N8O | NMR solution structure of aureocin A53 | solution nmr | A | — | — |
| 8AVS | Racemic protein crystal structure of aureocin A53 from Staphylococcus aureus in the presence of… | x-ray diffraction | A, B | — | — |
| 8AVT | Racemic protein crystal structure of aureocin A53 from Staphylococcus aureus in the presence of… | x-ray diffraction | B, A | G3P | — |
| 8AVU | Racemic protein crystal structure of aureocin A53 from Staphylococcus aureus in the dimeric state | x-ray diffraction | A | — | 1 (best 0.33) |
| Q8GPI4 | AlphaFold monomer V2.0 prediction for bacteriocin aureocin A53 (Q8GPI4) | predicted | A | — | — |
Ligands
- G3P · Sn-glycerol-3-phosphate · in 1 record
Experiment against prediction
- 8AVS chain A against the predicted model Q8GPI4: TM-score 0.98, RMSD 0.35 Å
- 8AVT chain A against the predicted model Q8GPI4: TM-score 0.98, RMSD 0.35 Å
- 8AVU chain A against the predicted model Q8GPI4: TM-score 0.98, RMSD 0.36 Å
- 8AVS chain B against the predicted model Q8GPI4: TM-score 0.97, RMSD 0.37 Å
- 8AVT chain B against the predicted model Q8GPI4: TM-score 0.97, RMSD 0.40 Å
- 2N8O chain A against the predicted model Q8GPI4: TM-score 0.93, RMSD 0.67 Å
- 2N8O chain A against the predicted model Q8GPI4: TM-score 0.93, RMSD 0.67 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.